About Detect-ION

R&D Expertise Driving Healthcare Innovation

Detect-ION is a deep-tech startup revolutionizing detection through non-invasive diagnostics and next generation diagnostics solutions.

Founded in October 2021, we operate from a state-of-the-art 4,000-square-foot laboratory in Tampa, FL, where we tackle high-value detection challenges requiring expertise in organic chemistry, biochemistry, gas chromatography, mass spectrometry, vacuum technology, data analytics, low-power electronics, system engineering, and artificial intelligence in healthcare applications. Our innovative medical diagnostic systems integrate advanced mass spectrometry with AI medical diagnosis capabilities to drive healthcare innovation.

Meet Our Team

Our Team


Our multi-disciplinary technical team represents decades of collective experience from world-class institutions, including SRI International, Draper, NIST, University of South Florida, and beyond. This exceptional group of scientists, engineers, and innovators brings together expertise spanning analytical chemistry, biomedical engineering, artificial intelligence, and advanced instrumentation development. The Detect-ION team has played a critical role in high-profile U.S. government programs to enhance chemical detection and security intelligence, while also pioneering breakthrough advances in point-of-care molecular diagnosis and testing technologies.

What sets our team apart is not just individual expertise, but our collaborative approach to solving complex detection challenges. The team's proven track record in both fundamental research and practical implementation positions Detect-ION at the forefront of next-generation diagnostic solutions.

View Timeline »

Founder

Ashish Chaudhary, Ph.D. Founder / CTO / CEO | R&D Expertise Driving Healthcare Innovation

Ashish Chaudhary, Ph.D.

Founder / CTO / CEO
With a diverse technical background and a relentless "scientist-turned-entrepreneur" grit, Ashish founded Detect-ION in 2021 to solve hard CBRNE sensing problems. At Detect-ION, he is applying his 21 years of S&T experience and a proven CRAD track record ($32M) in business development, technical execution, and programmatic management to solve the next set of sensing challenges in national security, environmental monitoring, and health diagnostics. Ashish has a PhD in Electrical Engineering from the University of South Florida and has developed a cross-domain expertise spanning across electrical engineering, mass spectrometry, gas chromatography, micro-fabrication, vacuum components and integration, system engineering, and rigorous testing and evaluation of CBRNE sensors in real-world applications
Technical Team
Katherine Hardwick, Chief Marketing Officer | R&D Expertise Driving Healthcare Innovation

Katherine Hardwick

Chief Marketing Officer
Connect »
Spiros Manolakos, Lead Clinical Scientist | R&D Expertise Driving Healthcare Innovation

Spiros Manolakos

Lead Clinical Scientist
Connect »
Gottfried Kibelka, Analytical Chemist | R&D Expertise Driving Healthcare Innovation

Gottfried Kibelka

Analytical Chemist
Connect »
Gregory Vasquez, Principal Scientist | R&D Expertise Driving Healthcare Innovation

Gregory Vasquez, Ph.D.

Principal Scientist 
Connect »
Bob Schweitzer, Senior Research Scientist | R&D Expertise Driving Healthcare Innovation

Bob Schweitzer, Ph.D.

Senior Research Scientist
Connect »
Detect-ION
Timeline

From Detect-ION's founding in 2021 to accessible point-of-care diagnostics and global health partnerships.

The Detect-ION Disruption
The Detect-ION Disruption

From the ashes of SRI International’s CBRNE System Laboratory, Detect-ION is founded with a bold mission: to democratize mass spectrometry. 

Joining TBTI
Joining TBTI

Detect-ION is inducted into the Tampa Bay Technology Incubator, USF’s catalyst for the creation and development of high-technology companies. Go Bulls!

Launching Our Lab
Launching Our Lab

Detect-ION inaugurates our first instrumentation lab at USF Connect, establishing a dedicated space for R&D to advance our sensor technology.

First Contract: EXHALE Program
First Contract: EXHALE Program

Detect-ION wins it’s first major contact: DTRA and DIU‘s EXHALE Program award to develop rapid, non-invasive breath diagnostics for pre-symptomatic infections.

Aerosol Detection: PICARD Program
Aerosol Detection: PICARD Program

Detect-ION is selected by IARPA to lead a multi-organizational team to develop an aerosolized chemical threat detection capability for the U.S. intelligence community under the PICARD program. 

Scaling Up: New Headquarters
Scaling Up: New Headquarters

Detect-ION expands our operations to centrally located 4,000 square-foot state-of-the-art laboratory in Tampa, FL.

Going Global: Gates Foundation
Going Global: Gates Foundation

The Gates Foundation selects Detect-ION to conduct a breath diagnostics trial for malaria and tuberculosis in low- and middle-income countries. 

HRMS Investment
HRMS Investment

Detect-ION invests in high-resolution mass spectrometry (HRMS) to facilitate breath biomarker discovery and point-of-care breath diagnostics pilots.

Tackling the Lung Cancer Survival Rate
Tackling the Lung Cancer Survival Rate

Detect-ION partners with Moffitt Cancer Center to develop lung cancer breath diagnostics.

Launching Our On-Site Breath Research Lab
Launching Our On-Site Breath Research Lab

Detect-ION opened our on-site Breath Research Lab facility to advance real-time breath diagnostics research. 

The Next Generation of 
Molecular Diagnostics
Has Arrived

Detect-ION stands at the forefront of healthcare innovation and next-generation sensor technologies, working alongside government agencies, research institutions, and industry leaders. The company's commitment to molecular point of care diagnostics ensures that advanced detection technologies are no longer limited to the lab—they're available when and where they're needed most.

Be Part of What's Next